Lunai Bioworks Inc.
LNAI • Biotechnology
$2.39
▲ +0.04 (+1.70%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$7.47M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.04Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 15, 2026, 12:00 AM UTCLast profile update: Aug 23, 2026, 12:08 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$2.39
Change1.70%
Shares Out3.12M
Market Cap$7.47M
Enterprise Value$5.30M
52W Range1.21 - 21.20
Beta0.32
P/E-0.06
P/S356.56
P/B-0.78
P/FCF-1.42
EV/Sales253.24
Price$2.39
Change1.70%
Shares Out3.12M
Market Cap$7.47M
Enterprise Value$5.30M
52W Range1.21 - 21.20
Beta0.32
P/E-0.06
P/S356.56
P/B-0.78
P/FCF-1.42
EV/Sales253.24
EV/EBITDA-0.04
EV/FCF-1.01
FCF Yield-70.44%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq-0.48
Current Ratio0.04
Quick Ratio0.04
Volume25.83K
Avg Volume972.56K
Investment DNA
How strong this company looks for long-term investors
33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Weak liquidity · 0.04Weak profitability
Analyst view
No analyst data available now.
🧾
No insider activity
No recent insider transactions available.